M&A Deal Summary

Teleflex Acquires Vascular Solutions

On December 2, 2016, Teleflex acquired medical products company Vascular Solutions for 1.0B USD

Acquisition Highlights
  • This is Teleflex’s 18th transaction in the Medical Products sector.
  • This is Teleflex’s 3rd largest (disclosed) transaction.
  • This is Teleflex’s 14th transaction in the United States.
  • This is Teleflex’s 1st transaction in Minnesota.

M&A Deal Summary

Date 2016-12-02
Target Vascular Solutions
Sector Medical Products
Buyer(s) Teleflex
Deal Type Add-on Acquisition
Deal Value 1.0B USD
Advisor(s) Guggenheim Securities (Financial)
Dorsey & Whitney (Legal)

Target

Vascular Solutions

Minneapolis, Minnesota, United States
Vascular Solutions, Inc. is a medical device developer. The company creates solutions for interventional cardiologists and interventional radiologists, including the D-Stat Dry hemostatic bandage, Pronto extraction catheter, Vari-Lase endovenous laser, Duett sealing device and D-Stat Flowable hemostat.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Teleflex

Wayne, Pennsylvania, United States

Category Company
Founded 1943
Sector Medical Products
Employees14,500
Revenue 3.0B USD (2023)
DESCRIPTION

Teleflex is a global provider of medical technology products that enhance clinical benefits, improve patient and provider safety and reduce total procedural costs. The Company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. Teleflex markets and sells its products to hospitals and healthcare providers worldwide through a combination of our direct sales force and distributors. Teleflex was founded in 1943 and is based in Wayne, Pennsylvania.


DEAL STATS #
Overall 22 of 28
Sector (Medical Products) 18 of 21
Type (Add-on Acquisition) 19 of 24
State (Minnesota) 1 of 1
Country (United States) 14 of 19
Year (2016) 2 of 2
Size (of disclosed) 3 of 13
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-01-11 Nostix

Boulder, Colorado, United States

Nostix LLC is a medical technology company that develops and commercializes differentiated PICC tip placement confirmation and navigation products.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-09-05 NeoTract

Pleasanton, California, United States

NeoTract, Inc. is a privately-held medical device company that has developed and commercialized the FDA-cleared UroLift® System, a novel, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia, or BPH. Performed primarily through a transurethral outpatient procedure, the UroLift® System delivers permanent implants that hold open the urethra, reducing the prostate obstruction without cutting, heating, or removing prostate tissue.

Buy $1.1B